RMD — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates RMD as Neutral with 74% confidence in the Healthcare sector.
AI Analysis Summary
RMD presents significant downside risk due to extreme leverage, bearish technicals, and a strong negative price forecast. the signal indicates unfavorable entry conditions.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 35/100
- Bill Ackman (Activist Investing): Grade B — 60/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $219.85
- Price target: $187.30 (-14.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: fair
- Competitive moat: none
Peer Group Analysis
RMD is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.